ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL
Two Onc Docs
00:00
Key takeaways for clinical practice
Kareen summarizes practical points: diagnostics, treatment triggers, and where pirtobrutinib might fit today.
Play episode from 09:40
Transcript
